Citigroup’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1,000K Sell
67,553
-108,693
-62% -$1.61M ﹤0.01% 2525
2025
Q1
$3.16M Buy
176,246
+39,090
+29% +$700K ﹤0.01% 1746
2024
Q4
$2.39M Buy
137,156
+79,555
+138% +$1.39M ﹤0.01% 2000
2024
Q3
$806K Buy
57,601
+12,648
+28% +$177K ﹤0.01% 2710
2024
Q2
$370K Sell
44,953
-462,080
-91% -$3.8M ﹤0.01% 2869
2024
Q1
$3.91M Buy
507,033
+294,970
+139% +$2.27M ﹤0.01% 1392
2023
Q4
$1.91M Sell
212,063
-121,308
-36% -$1.09M ﹤0.01% 1685
2023
Q3
$2.98M Buy
333,371
+67,909
+26% +$607K ﹤0.01% 1270
2023
Q2
$4.08M Sell
265,462
-96,609
-27% -$1.48M ﹤0.01% 1206
2023
Q1
$8.14M Buy
362,071
+216,863
+149% +$4.88M 0.01% 918
2022
Q4
$3.05M Sell
145,208
-46,176
-24% -$971K ﹤0.01% 1287
2022
Q3
$4.72M Buy
191,384
+54,490
+40% +$1.34M ﹤0.01% 1156
2022
Q2
$3.32M Buy
136,894
+107,049
+359% +$2.59M ﹤0.01% 1292
2022
Q1
$770K Sell
29,845
-114,539
-79% -$2.96M ﹤0.01% 2546
2021
Q4
$4.48M Sell
144,384
-91,443
-39% -$2.84M ﹤0.01% 1356
2021
Q3
$5.72M Buy
235,827
+25,308
+12% +$614K ﹤0.01% 1230
2021
Q2
$3.07M Buy
210,519
+85,578
+68% +$1.25M ﹤0.01% 1780
2021
Q1
$3.12M Buy
124,941
+112,971
+944% +$2.82M ﹤0.01% 1655
2020
Q4
$326K Buy
11,970
+7,370
+160% +$201K ﹤0.01% 2926
2020
Q3
$85K Sell
4,600
-27,214
-86% -$503K ﹤0.01% 3220
2020
Q2
$650K Sell
31,814
-2,876
-8% -$58.8K ﹤0.01% 2389
2020
Q1
$507K Buy
34,690
+19,327
+126% +$282K ﹤0.01% 2265
2019
Q4
$218K Sell
15,363
-112,692
-88% -$1.6M ﹤0.01% 3096
2019
Q3
$1.48M Buy
128,055
+23,117
+22% +$268K ﹤0.01% 1829
2019
Q2
$2.11M Buy
104,938
+80,777
+334% +$1.62M ﹤0.01% 1594
2019
Q1
$546K Sell
24,161
-59,237
-71% -$1.34M ﹤0.01% 2431
2018
Q4
$1.89M Buy
83,398
+58,641
+237% +$1.33M ﹤0.01% 1576
2018
Q3
$711K Buy
24,757
+4,168
+20% +$120K ﹤0.01% 2251
2018
Q2
$562K Buy
20,589
+14,826
+257% +$405K ﹤0.01% 2262
2018
Q1
$129K Sell
5,763
-33,221
-85% -$744K ﹤0.01% 3203
2017
Q4
$822K Buy
38,984
+20,351
+109% +$429K ﹤0.01% 2019
2017
Q3
$464K Sell
18,633
-7,177
-28% -$179K ﹤0.01% 2475
2017
Q2
$500K Buy
25,810
+5,082
+25% +$98.5K ﹤0.01% 2428
2017
Q1
$383K Sell
20,728
-85,642
-81% -$1.58M ﹤0.01% 2563
2016
Q4
$2.01M Buy
106,370
+89,322
+524% +$1.69M ﹤0.01% 1846
2016
Q3
$382K Buy
17,048
+9,714
+132% +$218K ﹤0.01% 2607
2016
Q2
$131K Sell
7,334
-23,905
-77% -$427K ﹤0.01% 3139
2016
Q1
$427K Buy
31,239
+27,986
+860% +$383K ﹤0.01% 2821
2015
Q4
$63K Sell
3,253
-17,722
-84% -$343K ﹤0.01% 3915
2015
Q3
$425K Buy
20,975
+16,474
+366% +$334K ﹤0.01% 2325
2015
Q2
$149K Sell
4,501
-467
-9% -$15.5K ﹤0.01% 2973
2015
Q1
$119K Sell
4,968
-4,267
-46% -$102K ﹤0.01% 3282
2014
Q4
$113K Buy
9,235
+8,458
+1,089% +$103K ﹤0.01% 3576
2014
Q3
$7K Buy
777
+418
+116% +$3.77K ﹤0.01% 4781
2014
Q2
$4K Sell
359
-1,640
-82% -$18.3K ﹤0.01% 4917
2014
Q1
$43K Buy
+1,999
New +$43K ﹤0.01% 4061